Catalyst Wire Dossier Catalyst Wire Dossier

Tirellizumab

Tirellizumab
Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for Tirellizumab, covering 2025-04-06 to 2025-12-05. Get the full timeline:

Most recent: Clinical Trial Update: Tirellizumab Combined With TP Neoadjuvant Therapy in the Treatment of Early Oral Squamous Cell Carcinoma (HNC-SYSU-005) [Phase 2]

See pricing